Search Results - "Soria-Rivas A"

1574P Medical oncology residents mentors (MORM): A target for resiliency interventions.

Authors: Paez, D. Lecumberri, A. Soria Rivas, A. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS952-S952. 1p.

1646P Efficiency of second-line BRAF/MEK inhibitors in BRAFV600 mutated metastatic melanoma patients after first-line immunotherapy failure: A EUMelaReg real-world study.

Authors: Ellebaek, E. Weichenthal, M. Gavrilova, I. et al.

Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS976-S977. 2p.

Limited T cell response to SARS-CoV-2 mRNA vaccine among patients with cancer receiving different cancer treatments.

Authors: Cortés, Alfonso Casado, José L. Longo, Federico et al.

Source: European Journal of Cancer. May2022, Vol. 166, p229-239. 11p.

1063P Influence of infusion timing on the outcomes of immunotherapy in a multi-tumor cohort.

Authors: Albarrán Fernández, V. Rosero Rodriguez, D.I. Chamorro-Perez, J. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS705-S706. 2p.

VP5-2024: Eftilagimod alpha (soluble LAG-3) and pembrolizumab in first-line recurrent or metastatic head and neck squamous cell carcinoma: Primary results from Cohort B (CPS less-than 1) of the TACTI-003 study.

Authors: Metcalf, R. Laban, S. Kristensen, C.A. et al.

Source: Annals of Oncology. Aug2024, Vol. 35 Issue 8, p754-755. 2p.

LBA35 Primary results from TACTI-003: A randomized phase IIb trial comparing eftilagimod alpha (soluble LAG-3) plus pembrolizumab versus pembrolizumab alone in first-line recurrent or metastatic head and neck squamous cell carcinoma with CPS ≥1.

Authors: Kristensen, C.A. Metcalf, R. Braña, I. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1227-S1227. 1p.

1849P Clinical predictors of long-term responses to immune checkpoint inhibitors (ICI) in a multi-tumor cohort.

Authors: Albarrán Fernández, V. Guerrero, P. Gonzalez Merino, C. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1090-S1090. 1p.

1022P A phase II trial of the IO102-IO103 vaccine plus pembrolizumab: Completed cohort for first-line (1L) treatment of advanced squamous cell carcinoma of the head and neck (SCCHN).

Authors: Riess, J.W. Spicer, J. Seiwert, T. et al.

Source: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS691-S691. 1p.

Change in cutaneous melanoma mortality rates in Spain after the introduction of new systemic treatments.

Authors: Hernández-Calle D Soria-Rivas A Beà-Ardébol S

Source: Clinical and experimental dermatology [Clin Exp Dermatol] 2026 Jul 24; Vol. 51 (8), pp. 1521-1524.

Publication Type: Journal Article

Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 7606847 Publication Model: Print Cited Medium: Internet ISSN: 1365-2230 (Electronic) Linking ISSN: 03076938 NLM ISO Abbreviation: Clin Exp Dermatol Subsets: MEDLINE; In Process

Recommendations for the management of cutaneous squamous cell carcinoma: a systematic multidisciplinary Delphi consensus approach.

Authors: Muñoz Couselo E Cañueto J Jerviz Guía V et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2025 Jul; Vol. 27 (7), pp. 3058-3072. Date of Electronic Publication: 2024 Dec 19.

Publication Type: Journal Article; Consensus Statement

Journal Info: Publisher: Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

SEOM clinical guidelines for cancer anorexia-cachexia syndrome (2023).

Authors: Soria Rivas A Escobar Álvarez Y Blasco Cordellat A et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2024 Nov; Vol. 26 (11), pp. 2866-2876. Date of Electronic Publication: 2024 Jun 01.

Publication Type: Journal Article; Review; Practice Guideline

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Fatal hemoptysis due to massive cavitation of lung metastases in a patient with adenoid cystic carcinoma treated with lenvatinib.

Authors: Gorospe L Lage-Alfranca Y Soria-Rivas A et al.

Source: Medicina clinica [Med Clin (Barc)] 2025 Sep; Vol. 165 (3), pp. 106955. Date of Electronic Publication: 2025 May 22.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier España Country of Publication: Spain NLM ID: 0376377 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1578-8989 (Electronic) Linking ISSN: 00257753 NLM ISO Abbreviation: Med Clin (Barc) Subsets: MEDLINE; In Process

Phase Ib Study of Immunocytokine Simlukafusp Alfa (FAP-IL2v) Combined with Pembrolizumab for Treatment of Advanced and/or Metastatic Melanoma.

Authors: Munoz-Couselo E Soria Rivas A Sandhu S et al.

Source: Cancer research communications [Cancer Res Commun] 2025 Feb 01; Vol. 5 (2), pp. 358-368.

Publication Type: Journal Article; Clinical Trial, Phase I; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE

Correction to: Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

Authors: Trigo J García-Cosío M García-Castaño A et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2023 Jan; Vol. 25 (1), pp. 292.

Publication Type: Published Erratum

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE; PubMed not MEDLINE

A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.

Authors: Hughes BGM Guminski A Bowyer S et al.

Source: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2025 Jan; Vol. 92 (1), pp. 68-77. Date of Electronic Publication: 2024 Sep 07.

Publication Type: Journal Article; Clinical Trial, Phase II; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Mosby Country of Publication: United States NLM ID: 7907132 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6787 (Electronic) Linking ISSN: 01909622 NLM ISO Abbreviation: J Am Acad Dermatol Subsets: MEDLINE

Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: a consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

Authors: Trigo J García-Cosío M García-Castaño A et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2022 Oct; Vol. 24 (10), pp. 1890-1902. Date of Electronic Publication: 2022 Jun 23.

Publication Type: Journal Article; Consensus Statement

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Sarcoidosis-like reactions in cancer patients treated with immune checkpoint inhibitors: experience in a Spanish hospital.

Authors: Torres-Jiménez J Esteban-Villarrubia J García-Abellás P et al.

Source: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico [Clin Transl Oncol] 2021 Jul; Vol. 23 (7), pp. 1474-1480. Date of Electronic Publication: 2021 Jan 12.

Publication Type: Journal Article

Journal Info: Publisher: Springer Italia Country of Publication: Italy NLM ID: 101247119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1699-3055 (Electronic) Linking ISSN: 1699048X NLM ISO Abbreviation: Clin Transl Oncol Subsets: MEDLINE

Intratumoral nanoplexed poly I:C BO-112 in combination with systemic anti-PD-1 for patients with anti-PD-1-refractory tumors.

Authors: Márquez-Rodas I Longo F Rodriguez-Ruiz ME et al.

Source: Science translational medicine [Sci Transl Med] 2020 Oct 14; Vol. 12 (565).

Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101505086 Publication Model: Print Cited Medium: Internet ISSN: 1946-6242 (Electronic) Linking ISSN: 19466234 NLM ISO Abbreviation: Sci Transl Med Subsets: MEDLINE

Treatment of metastatic squamous cell carcinoma arising in sacrococcygeal pilonidal sinus: a case report series.

Authors: Soria Rivas A Bea-Ardebol S Vida Navas E et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2023 Sep 13; Vol. 10, pp. 1248894. Date of Electronic Publication: 2023 Sep 13 (Print Publication: 2023).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

Recommendations for the use of biomarkers for head and neck cancer, including salivary gland tumours: A Consensus of the Spanish Society of Medical Oncology and the Spanish Society of Pathology.

Authors: Pérez JMT García-Cosío M García-Castaño A et al.

Source: Revista espanola de patologia : publicacion oficial de la Sociedad Espanola de Anatomia Patologica y de la Sociedad Espanola de Citologia [Rev Esp Patol] 2023 Jan-Mar; Vol. 56 (1), pp. 45-57. Date of Electronic Publication: 2022 Aug 27.

Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't; Consensus Statement

Journal Info: Publisher: Elsevier España Country of Publication: Spain NLM ID: 100885154 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1988-561X (Electronic) Linking ISSN: 16998855 NLM ISO Abbreviation: Rev Esp Patol Subsets: MEDLINE